BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32115019)

  • 1. Excess length of hospital stay, mortality and cost attributable to
    Kimura T; Stanhope S; Sugitani T
    Epidemiol Infect; 2020 Mar; 148():e65. PubMed ID: 32115019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
    Kunishima H; Ito K; Laurent T; Abe M
    J Infect Chemother; 2018 Nov; 24(11):892-901. PubMed ID: 30190105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries.
    Eckmann C; Wasserman M; Latif F; Roberts G; Beriot-Mathiot A
    Eur J Health Econ; 2013 Oct; 14(5):835-46. PubMed ID: 23797490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
    Mollard S; Lurienne L; Heimann SM; Bandinelli PA
    J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study.
    Bouza E; Cobo J; Rodríguez-Hernández MJ; Salavert M; Horcajada JP; Iribarren JA; Obi E; Lozano V; Maratia S; Cuesta M; Uría E; Limón E
    Rev Esp Quimioter; 2021 Apr; 34(2):126-135. PubMed ID: 33618513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
    Kimura T; Stanhope S; Sugitani T
    J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
    Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
    Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A
    J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study.
    Antunes A; Tricotel A; Wilk A; Dombrowski S; Rinta-Kokko H; Andersson FL; Ghosh S
    BMC Infect Dis; 2024 May; 24(1):548. PubMed ID: 38822244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.
    Wilcox MH; Ahir H; Coia JE; Dodgson A; Hopkins S; Llewelyn MJ; Settle C; Mclain-Smith S; Marcella SW
    J Antimicrob Chemother; 2017 Sep; 72(9):2647-2656. PubMed ID: 28633368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care resource utilization and costs of recurrent
    Nelson WW; Scott TA; Boules M; Teigland C; Parente A; Unni S; Feuerstadt P
    J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
    [No Abstract]   [Full Text] [Related]  

  • 19. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.
    Sammons JS; Localio R; Xiao R; Coffin SE; Zaoutis T
    Clin Infect Dis; 2013 Jul; 57(1):1-8. PubMed ID: 23532470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes.
    Tresman R; Goldenberg SD
    J Antimicrob Chemother; 2018 Oct; 73(10):2851-2855. PubMed ID: 29982502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.